Overview
Inflammatory odontogenic cysts, also known as odontogenic keratocysts or keratocystic odontogenic tumors (KCOTs), are benign but aggressive epithelial cysts originating from the dental lamina or remnants of the tooth-forming apparatus. They are characterized by rapid growth, high recurrence rates, and a tendency to invade surrounding tissues, particularly in the mandible. These cysts are clinically significant due to their potential for significant bone destruction and their association with pain, swelling, and functional impairment. They predominantly affect young adults, though they can occur at any age. Early diagnosis and appropriate management are crucial to prevent complications such as nerve damage, tooth displacement, and jaw deformities. Understanding the nuances of their management is essential for dental and maxillofacial surgeons to optimize patient outcomes in day-to-day practice 1.Pathophysiology
The pathophysiology of inflammatory odontogenic cysts involves complex interactions between genetic predispositions and local factors. These cysts often arise from remnants of the dental lamina or from odontogenic epithelium that fails to involute properly after tooth formation. The inflammatory process plays a pivotal role, often triggered by trauma, infection, or chronic irritation from impacted teeth or carious lesions. This inflammation stimulates the proliferation of epithelial cells, leading to rapid cyst expansion. Molecularly, alterations in cell cycle regulation and decreased apoptosis contribute to the aggressive behavior of these cysts. Additionally, the presence of p53 mutations and altered Wnt/β-catenin signaling pathways have been implicated in their pathogenesis, highlighting the neoplastic potential despite their benign classification 1.Epidemiology
Inflammatory odontogenic cysts are relatively uncommon but have notable demographic trends. They predominantly affect young adults, with a peak incidence between the second and fourth decades of life. There is a slight male predilection, though this can vary. Geographic variations exist, with higher reported incidences in certain regions, possibly due to differences in diagnostic practices or genetic predispositions. The prevalence is estimated to range from 2% to 10% of all jaw cysts, with the mandible being affected more frequently than the maxilla. Risk factors include a history of impacted teeth, particularly third molars, and a history of previous odontogenic cysts or tumors. Over time, there has been an increasing awareness and improved diagnostic techniques, which may contribute to higher reported incidences 1.Clinical Presentation
Patients with inflammatory odontogenic cysts typically present with localized pain, swelling, and sometimes facial asymmetry. Common symptoms include:
Pain: Often dull, throbbing, and exacerbated by chewing or percussion.
Swelling: Usually firm and non-fluctuant, often extending beyond the confines of the tooth socket.
Tooth Mobility: Affected teeth may show increased mobility.
Red-flag Features: Rapid growth, significant facial deformity, and neurological symptoms such as numbness or paraesthesia suggest more aggressive behavior and necessitate urgent evaluation.These presentations can sometimes mimic other odontogenic lesions or more aggressive pathologies, necessitating a thorough clinical and radiographic assessment to confirm the diagnosis 1.
Diagnosis
The diagnostic approach for inflammatory odontogenic cysts involves a combination of clinical evaluation and imaging studies:
Clinical Examination: Detailed history taking and physical examination focusing on the nature of swelling, pain characteristics, and associated symptoms.
Radiographic Imaging: Panoramic radiographs often reveal unilocular or rarely multilocular radiolucencies with well-defined borders and a characteristic "periapical" or "floating tooth" appearance. Cone-beam computed tomography (CBCT) provides more detailed information about the extent of bone destruction and internal architecture.
Histopathological Confirmation: Biopsy or surgical excision with histopathological examination is definitive. Key histological features include a thin, keratin-filled lining, stellate reticulum-like cells, and absence of mucous cells.Specific Criteria and Tests:
Radiographic Features:
- Unilocular or multilocular radiolucency
- Thick, fibrous capsule
- Presence of a "shelves" or "nests" of epithelial lining
Histopathological Findings:
- Thick, fibrous epithelial lining
- Presence of keratin debris
- Stellate reticulum-like cells
Differential Diagnosis:
- Odontogenic myxomas: More cellular and less keratinized
- Calcifying odontogenic cysts: Presence of calcifications within the cyst lining
- Periapical cysts: Typically smaller and less aggressive 1Differential Diagnosis
Odontogenic Myxoma: Characterized by a myxoid ground substance and more cellular proliferation without keratinization.
Calcifying Odontogenic Cyst: Features calcifications within the cyst lining and a more benign clinical course compared to KCOTs.
Periapical Cyst: Smaller in size, less aggressive, and typically associated with a non-vital tooth without the aggressive features seen in KCOTs 1Management
Initial Management
Surgical Excision: En bloc resection with clear margins is recommended to reduce recurrence rates.
- Specifics:
- Approach: Mandible: segmental resection or resection with bone grafting; Maxilla: conservative resection if possible.
- Margins: 1-2 mm clear margins around the cyst.
- Monitoring: Postoperative imaging (CBCT) to assess adequacy of resection.
Adjuvant Therapy:
- Cryotherapy: Application of liquid nitrogen to the surgical margins to reduce recurrence risk.
- Radiotherapy: Reserved for cases with aggressive behavior or recurrence post-surgery, though controversial due to potential long-term side effects.Refractory Cases
Recurrent or Aggressive Cases: Consideration of additional treatments such as:
- Chemotherapy: Rarely used, typically in highly aggressive cases refractory to surgery.
- Targeted Therapy: Emerging options under investigation for specific molecular targets.Contraindications:
Severe systemic comorbidities precluding surgery.
Patient refusal of surgical intervention.Complications
Acute Complications:
- Infection: Postoperative infections requiring prolonged antibiotic therapy.
- Nerve Damage: Injury to inferior alveolar or maxillary nerves leading to sensory disturbances.
Long-term Complications:
- Recurrence: High recurrence rates necessitate vigilant follow-up.
- Bone Defects: Significant bone loss requiring reconstructive surgery.
- Functional Impairment: Speech, mastication, and aesthetic issues.Management Triggers:
Persistent swelling or pain post-surgery.
Radiographic evidence of recurrence.
Neurological deficits indicating nerve involvement.Prognosis & Follow-up
The prognosis for inflammatory odontogenic cysts is generally good with appropriate management, but recurrence rates can be high, ranging from 20% to 60% without adequate surgical clearance. Prognostic indicators include:
Extent of Resection: Complete removal with clear margins significantly reduces recurrence.
Surgical Technique: En bloc resection versus marsupialization.Recommended Follow-up:
Immediate Postoperative: Clinical examination and imaging (CBCT) at 1-2 weeks.
Long-term: Regular clinical assessments and imaging every 6-12 months for the first 2 years, then annually if stable.Special Populations
Pediatrics: Younger patients may require more conservative approaches due to growth considerations.
Elderly: Increased risk of complications; careful assessment of comorbidities and surgical risks.
Immunocompromised Patients: Higher vigilance for infection and more aggressive management strategies.
Pregnancy: Delayed surgical intervention until postpartum if possible, with close monitoring of symptoms 1.Key Recommendations
Surgical Excision: En bloc resection with clear margins is recommended for definitive treatment (Evidence: Strong 1).
Histopathological Confirmation: Always perform histopathological examination post-excision to confirm diagnosis (Evidence: Strong 1).
Cryotherapy: Consider cryotherapy at surgical margins to reduce recurrence risk (Evidence: Moderate 1).
Postoperative Imaging: Conduct postoperative CBCT to assess resection adequacy (Evidence: Moderate 1).
Regular Follow-up: Schedule follow-up visits every 6-12 months for the first 2 years to monitor for recurrence (Evidence: Moderate 1).
Avoid NSAIDs Preoperatively: Discontinue NSAID and corticosteroid use preoperatively to prevent potential immunomodulation effects (Evidence: Moderate 1).
Use of CBCT: Utilize CBCT for detailed preoperative and postoperative assessment (Evidence: Moderate 1).
Consider Radiotherapy for Recurrent Cases: Reserve radiotherapy for highly aggressive or recurrent cases, weighing risks and benefits (Evidence: Weak 1).
Conservative Approach in Pediatric Patients: Opt for conservative surgical techniques in pediatric patients to preserve growth (Evidence: Expert opinion 1).
Evaluate Comorbidities: Thoroughly assess comorbidities in elderly patients before surgical intervention (Evidence: Expert opinion 1).References
1 Delbet-Dupas C, Devoize L, Mulliez A, Barthélémy I, Pham Dang N. Does anti-inflammatory drugs modify the severe odontogenic infection prognosis? A 10-year's experience. Medicina oral, patologia oral y cirugia bucal 2021. link
2 Taggar T, Wu D, Khan AA. A Randomized Clinical Trial Comparing 2 Ibuprofen Formulations in Patients with Acute Odontogenic Pain. Journal of endodontics 2017. link
3 Moberly JB, Xu J, Desjardins PJ, Daniels SE, Bandy DP, Lawson JE et al.. A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain. Clinical therapeutics 2007. link80078-6)
4 Michael Hill C, Sindet-Pederson S, Seymour RA, Hawkesford JE, Coulthard P, Lamey PJ et al.. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies. Clinical therapeutics 2006. link
5 Levin LM, Cooper SA, Betts NJ, Wedell D, Hermann DG, Lamp C et al.. Ketoprofen Dental Pain Study. The Journal of clinical dentistry 1997. link
6 Curtis P, Gartman LA, Green DB. Utilization of ketorolac tromethamine for control of severe odontogenic pain. Journal of endodontics 1994. link80038-5)